Pegasys approved for PV and ET in Europe, Good news?

[SamHathaway1800]

ema.europa.eu/en/medicines/...

It looks like Pegasys has been approved by the European EMA for treating PV and ET.

Although Pegasys has been used to treat these diseases for some time, it was previously off-label.

This should be good news for European patients, and hopefully, it will soon be included in national health insurance. I wonder if the company now holds the marketing right of Pegasys has made the same application in the US?

Anyway, more treatment options are always better for patients, so I hope this could also positively impact insurance coverage for US patients.

[Aquinas]

That sounds like very good news. Thank you for the info.

[kamiilos]

Hi, I know in some European countries they discontinued Pegasys for Besremi.

Wish they could approve it in Australia

Thank you for sharing

[Aldebaran25]

Besremi is already approved in EU. I hope this doesn’t mean public health will opt for the cheaper of the two only. I find Bes is working better for me than Peg.

[Purplechoclover]

Thats great news, ive been on pegasys since January and the side effects have been manageable

[AndyT]

Thanks for sharing this good news!

Technically this is still a recommendation and won’t be final until the EU Commission decision is confirmed but hopefully that is just a formality and will be issued within the next two months or so.

It should be good news in EU countries where off-label use of Pegasys has been restricted and will hopefully lead to approval in other countries, such as the UK, where Pegasys is widely used in ET and PV but remains off-label.

Hopefully it also gives the new manufacturer the confidence to continue investing in and distributing Pegasys, for which they recently acquired the licence from Roche.

[Grapefruitlohoff]

Thanks for sharing!